+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05142787

International Study of Magseed Pro and Sentimag Gen3 for Marking Breast Lesions and Positive Lymph Nodes in Breast Cancer Patients

Led by Endomagnetics Ltd. · Updated on 2026-09-16

224

Participants Needed

6

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the safety and effectiveness of the Magseed Pro marker and Sentimag Gen3 system for marking suspicious or biopsy-proven positive axillary lymph nodes and soft tissue breast lesions, including cancerous and precancerous changes. It is a multicenter, international, open-label study involving patients with breast andor lymph node conditions requiring surgical excision. The study is focused on providing prospective evidence for these devices in guiding surgical removal. Participants will have the Magseed Pro marker placed percutaneously under imaging guidance to mark either axillary lymph nodes or breast lesions targeted for surgical removal. The Sentimag Gen3 system is then used to localize the marker during surgery, helping surgeons accurately remove the targeted tissue. The trial plans to enroll 224 patients, split evenly between those with markers placed in lymph nodes and those with markers placed in breast lesions. Each participants involvement lasts approximately 1 to 38 weeks from enrollment. During the study, researchers will track marker retrieval rates within the excised tissue at the time of surgery, monitor tissue responses, and record any device-related adverse events throughout the study duration. Other assessments include ease of marker placement and localization, re-excision rates, and marker position stability. Participants will undergo imaging and surgical procedures as part of their routine care, with follow-up visits as needed to monitor outcomes and safety over an average of 38 weeks.

CONDITIONS

Brief Title

Magseed Pro(R)/ Sentimag(R) Gen3

Research Team

M

Matt Womack, Dr

T

Tanja Odeneg, Dr

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here